MRAI Marpai, Inc.
Services-Misc Health & Allied Services, NEC · OTC · SEC CIK 1844392 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-17.8%
TTM net income YoY-37.9%
TTM EPS YoY-6.2%
Revenue 3-yr CAGR-22.1%
Net income 3-yr CAGR—
Margins
Gross margin25.0%
Operating margin-78.4%
Net margin-98.0%
FCF margin—
EBITDA margin-77.7%
Returns
ROE—
ROA-141.5%
ROIC (approx.)—
Asset turnover1.44x
Leverage & solvency
Liabilities / assets375.3%
Debt / equity—
Current ratio0.65x
Interest coverage-3.64x
Cash quality & payout
Operating cash flow / net income0.98x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.42M | $4.17M | $4.44M | $3.99M | $4.04M | $4.66M | $5.42M | $6.59M |
| Cost of revenue | $3.40M | $3.17M | $3.24M | $2.96M | $2.96M | $3.91M | $3.48M | $3.99M |
| Gross profit | $1.02M | $997,000 | $1.21M | $1.03M | $1.07M | $746,000 | $1.93M | $2.60M |
| R&D expense | — | — | — | $0 | $0 | $0 | $7,000 | $7,000 |
| SG&A expense | $2.14M | $3.07M | $2.13M | $4.31M | $2.07M | $2.48M | $2.28M | $2.88M |
| Operating income | -$2.51M | -$3.43M | -$2.48M | -$4.93M | -$2.77M | -$3.61M | -$2.25M | -$2.69M |
| Interest expense | $857,000 | $1.23M | $775,000 | $804,000 | $797,000 | $813,000 | $819,000 | $819,000 |
| Pretax income | -$3.29M | -$4.58M | -$3.18M | -$5.63M | -$3.49M | -$4.37M | -$3.07M | -$2.35M |
| Net income | -$3.29M | -$4.58M | -$3.18M | -$5.63M | -$3.49M | -$4.37M | -$3.07M | -$1.16M |
| EBITDA | -$2.51M | -$3.43M | -$2.42M | -$4.87M | -$2.66M | -$3.50M | -$2.14M | -$2.51M |
| EPS (basic) | -0.13 | -0.18 | -0.13 | — | -0.20 | -0.28 | -0.21 | — |
| EPS (diluted) | -0.13 | -0.18 | -0.13 | — | -0.20 | -0.28 | -0.21 | — |
| Weighted avg. shares (diluted) | 26.83M | 25.86M | 24.68M | — | 17.30M | 15.50M | 14.77M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $360,000 | $138,000 | $201,000 | $133,000 | $10.52M | $8.28M | $8.28M | $9.23M |
| Receivables | $940,000 | $1.02M | $738,000 | $697,000 | $377,000 | $548,000 | $368,000 | $837,000 |
| Current assets | $10.37M | $9.00M | $10.43M | $10.34M | $12.08M | $10.33M | $12.87M | $11.90M |
| PP&E, net | — | — | — | $0 | — | — | — | $0 |
| Intangibles | — | — | — | $60,000 | — | — | — | $441,000 |
| Total assets | $10.81M | $9.47M | $10.91M | $10.90M | $12.75M | $11.06M | $13.72M | $12.88M |
| Current liabilities | $15.86M | $23.55M | $27.15M | $25.69M | $22.78M | $19.73M | $19.79M | $18.98M |
| Short-term debt | $2.00M | $2.45M | $8.00M | $8.00M | $2.81M | $2.81M | $2.81M | $6.10M |
| Long-term debt | $18.76M | $18.28M | $11.88M | $19.40M | $16.14M | $15.69M | $15.25M | $17.79M |
| Total debt | $20.76M | $20.73M | $19.88M | $27.40M | $18.95M | $18.50M | $18.05M | $23.89M |
| Total liabilities | $40.58M | $48.36M | $46.16M | $43.47M | $46.10M | $43.43M | $43.92M | $40.59M |
| Shareholders' equity | -$29.77M | -$38.89M | -$35.24M | -$32.56M | -$33.35M | -$32.37M | -$30.20M | -$27.71M |
| Net debt | $20.40M | $20.59M | $19.68M | $27.27M | $8.44M | $10.22M | $9.78M | $14.66M |
| Shares outstanding | 26.88M | 26.67M | 25.29M | 24.04M | 18.46M | 16.54M | 14.90M | 14.24M |
| Cash flow statement | ||||||||
| Operating cash flow | -$6.98M | -$4.10M | -$477,000 | -$4.76M | $634,000 | -$3.21M | -$115,000 | -$4.91M |
| Investing cash flow | — | — | — | $0 | $0 | $0 | $500,000 | $0 |
| Financing cash flow | $8.18M | $2.04M | $160,000 | $3.20M | $1.60M | -$20,000 | $1.89M | $2.10M |
| Depreciation & amortization | $0 | $0 | $60,000 | $60,000 | $107,000 | $107,000 | $107,000 | $178,000 |
| Stock-based compensation | $132,000 | $917,000 | $203,000 | $2.16M | $22,000 | $33,000 | $574,000 | $371,000 |
Free plan shows the latest 8 periods; Pro shows all 25 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.